C vs LRMR · P/E 16, rev $85.22B vs $204.9M cap
Citigroup Inc. (C) versus Larimar Therapeutics Inc (LRMR) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Larimar Therapeutics Inc (LRMR) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
LRMR does not have a complete income-statement cache yet.
C currently screens at market cap $214.73B and trailing P/E 15.5. LRMR currently screens at market cap $204.9M.
Not investment advice. Open the C and LRMR stock pages for the full models.
Not investment advice.